Bryan Haynes, a partner in the Troutman Pepper Tobacco Team, will present a tobacco and e-vapor regulatory update and participate in a panel discussion at the CSP EduNetworking Tobacco/OTP + CBD Forum in Miami, Florida on November 17 and 19, 2021.

Bryan will discuss the current state of affairs in tobacco e-vapor laws and regulations,

More than a year and a half ago, in March 2020, the U.S. Food and Drug Administration (FDA) issued its final rule on a graphic-warning requirement for cigarettes. The rule—initially slated to take effect June 18, 2021—would require 11 new textual, health warning statements accompanied by color, “photorealistic” images displayed on the top 50% of the front and rear panels of cigarette packs and top 20% of cigarette ads. The rule’s effective date, however, has been extended multiple times by court order and is currently set for October 11, 2022. So when might tobacco manufacturers need to start producing new cigarette packs and ads?
Continue Reading When Might FDA’s Graphic Warning Rule for Cigarettes Take Effect?

As of October 20, 2021, the final rule of the U.S. Postal Service (the “USPS”) regarding the treatment of electronic nicotine delivery systems (“ENDS”) in the mail is available for public inspection via the link here.  The final rule generally prohibits the mailing of ENDS, subject to certain exceptions, as of the date of its publication in the Federal Register, which we understand will be tomorrow, October 21, 2020.  We also expect that as of October 21st, USPS will publish accompanying implementation materials on its websites.  
Continue Reading U.S. Postal Service Sets Rule Prohibiting the Mailing of ENDS Products

Governor Gavin Newsome recently signed California Assembly Bill 45 (AB 45) into law, which, among other things, allows hemp-derived cannabidiol (CBD) to be included in any food, beverages, and dietary supplements sold in California. This is not only a break from California’s prior position prohibiting CBD from being included in such products even as the State began to tax and regulate its cannabis industry, but it is also in stark contrast with the U.S. Food and Drug Administration’s (FDA’s) current position on the issue.
Continue Reading California Passes CBD Law That Conflicts With FDA Guidance

The Troutman Pepper Tobacco Team will participate in the Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference.  The event is virtual and will be held October 27–29, 2021.

Join a diverse group of stakeholders – public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others

On October 5, 2021, the Food and Drug Administration (“FDA”) published in the Federal Register its Final Rule on the content and format of reports intended to demonstrate the substantial equivalence of a tobacco product (“SE Reports”). The rule originally was displayed in January in the Federal Register, but was quickly retracted by the Biden Administration and did not publish.
Continue Reading FDA (Re)Issues Final Rule on Substantial Equivalence

It is widely known that trafficking in controlled substances is a crime under federal law. Traffickers and would-be traffickers be warned, however, that if you do choose to make income from trafficking in Schedule I or II controlled substances (including cannabis, cocaine, or psychedelic mushrooms), that income is fully taxable by the U.S. government. And, if you have employees helping you produce and sell federal Schedule I or II controlled substances (as many state-legal cannabis businesses do), you owe federal employment taxes as well.
Continue Reading IRS Launches Cannabis-Industry Focused Compliance Initiative

The term tetrahydrocannabinol (THC) is most often associated with the delta-9 THC cannabinoid, which is one of over 100 cannabinoids found in both high-THC marijuana and low-THC hemp. Delta-9 THC is also the cannabinoid most often responsible for getting cannabis users “high” and is the cannabinoid that has been explicitly prohibited by the federal Controlled Substances Act (CSA).
Continue Reading Delta-8’s 2018 Farm Bill Honeymoon May Be Slowly Coming to an End

On Wednesday, the Massachusetts Supreme Judicial Court upheld a jury’s award of $10 million in punitive damages in a wrongful-death case against Philip Morris USA Inc. (“PM USA”), rejecting the tobacco company’s argument that such relief was precluded by the 1998 master settlement agreement between the Massachusetts Attorney General, PM USA, and other attorneys general and tobacco manufacturers.[1]

Continue Reading Massachusetts Supreme Judicial Court Affirms Punitive Damages Award Against Philip Morris USA Inc. In Spite of Master Settlement Agreement Release

Bryan Haynes of the Troutman Pepper Tobacco Team was recently interviewed for CSP’s Tobacco Regulatory Update.  The article discusses six regulatory issues at the federal, state and local levels that could impact tobacco retailers:

  • The impact of the Biden administration on tobacco laws and regulations
  • FDA’s progress in reviewing requests for marketing authorization for new tobacco products
  • The potential that tobacco retailers may be required to post in their stores “corrective statements” regarding the consequences of smoking
  • The ongoing litigation regarding FDA’s new graphic health warnings for cigarettes.
  • Potential flavor bans.
  • Potential excise tax increases.


Continue Reading Troutman Pepper Tobacco Team Interviewed for CSP Tobacco Regulatory Update